Loss of KDM6A Characterizes a Poor Prognostic Subtype of Human Pancreatic Cancer and Potentiates HDAC Inhibitor Lethality

International Journal of Cancer - United States
doi 10.1002/ijc.32072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

KDM6A Loss Induces Aggressive Pancreatic Cancer in Mice

Cancer Discovery
Oncology
2018English

Collateral Lethality in Pancreatic Cancer

Cancer Discovery
Oncology
2017English

Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-Like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

CCDC88A, a Prognostic Factor for Human Pancreatic Cancers, Promotes the Motility and Invasiveness of Pancreatic Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2016English

Loss of HNF6 Expression Correlates With Human Pancreatic Cancer Progression

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2014English

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

Low Expression of Aldehyde Deyhdrogenase 1A1 (ALDH1A1) Is a Prognostic Marker for Poor Survival in Pancreatic Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Lysophosphatidic Acid Protects Cancer Cells From Histone Deacetylase (HDAC) Inhibitor-Induced Apoptosis Through Activation of HDAC

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy